TechnipFMC PLC (0RMV)
London Stock Exchange · UK · prices in GBP · close of 29 Oct 2026
Key indicators
| Last close | GBP 60.20 |
|---|---|
| 52-week range | 35.30 – 69.40 |
| Return, 1 month / 3 months | −0.5% / −5.2% |
| Return, 1 year / 3 years | +70.5% / +197.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -17.3% |
| Average daily value traded | 0.00M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
TechnipFMC is an energy technology company that supplies equipment and services to the oil and gas industry. It designs and manufactures subsea production systems, including trees, manifolds and flexible pipes, and provides surface wellhead and pressure control equipment for onshore and offshore operations. Its customers are oil and gas operators and exploration and production companies. The company is incorporated in the United Kingdom and maintains major operations in several countries, serving offshore and onshore fields around the world.
The shares are listed on the London Stock Exchange in UK under the code 0RMV, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
TechnipFMC PLC (0RMV) trades on the London Stock Exchange in UK. It last closed at GBP 60.20 on 29 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 2,048 of 3,789 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 70.5% and over the last three months it fell 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.7% | ||
| From 52-week high | -13.3% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.2% | ||
| 6-month return | -7.5% | ||
| 12-month return, skipping the last month | 71.4% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.3% | ||
| Liquidity | 4 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M GBP | ||
| Zero-volume days | 81.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | −0.5% |
| 3 months | −5.2% |
| 6 months | −7.5% |
| 1 year | +70.5% |
| 3 years | +197.9% |
| 5 years | +828.6% |
Signals
| 50-day / 200-day average | 63.60 / 59.77 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Aug 2026 | GBX 0.0004 |
| 18 May 2026 | GBX 0.0004 |
| 16 Mar 2026 | GBX 0.0004 |
| 17 Nov 2025 | GBX 0.0004 |
| 19 Aug 2025 | GBX 0.0004 |
| 19 May 2025 | GBX 0.0004 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.